» Articles » PMID: 35323718

Novel Psychoactive Substances: The Razor's Edge Between Therapeutical Potential and Psychoactive Recreational Misuse

Overview
Specialty Pharmacology
Date 2022 Mar 24
PMID 35323718
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Novel psychoactive substances (NPS) are compounds of natural and synthetic origin, similar to traditional drugs of abuse. NPS are involved in a contemporary trend whose origin lies in a thinner balance between legitimate therapeutic drug research and legislative control. The contemporary NPS trend resulted from the replacement of MDMA by synthetic cathinones in 'ecstasy' during the 2000s. The most common NPS are synthetic cannabinoids and synthetic cathinones. Interestingly, during the last 50 years, these two classes of NPS have been the object of scientific research for a set of health conditions.

Methods: Searches were conducted in the online database PubMed using boolean equations.

Results: Synthetic cannabinoids displayed protective and therapeutic effects for inflammatory, neurodegenerative and oncologic pathologies, activating the immune system and reducing inflammation. Synthetic cathinones act similarly to amphetamine-type stimulants and can be used for depression and chronic fatigue.

Conclusions: Despite the scientific advances in this field of research, pharmacological application of NPS is being jeopardized by fatalities associated with their recreational use. This review addresses the scientific achievements of these two classes of NPS and the toxicological data, ending with a reflection on Illicit and NPS control frames.

Citing Articles

Disposition Kinetics of Cathinone and its Metabolites after Oral Administration in Rats.

Sabei F, Khardali I, Al-Kasim M, Shaheen E, Oraiby M, Alamir A Curr Drug Metab. 2024; 25(3):220-226.

PMID: 38752643 DOI: 10.2174/0113892002300638240513065512.


The Designer Drug αPHP Affected Cell Proliferation and Triggered Deathly Mechanisms in Murine Neural Stem/Progenitor Cells.

Roda E, De Luca F, Priori E, Ratto D, Pinelli S, Corradini E Biology (Basel). 2023; 12(9).

PMID: 37759624 PMC: 10525791. DOI: 10.3390/biology12091225.


Colorimetric and fluorescent detection of synthetic cathinones in oral fluid with -aryl BODIPYs and Cu(ii).

Hernandez-Contreras J, Parra M, Gil S, Costero A, Arroyo P, Sancenon F RSC Adv. 2022; 12(44):28580-28585.

PMID: 36330338 PMC: 9583296. DOI: 10.1039/d2ra05188e.


3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.

Lopez-Arnau R, Camarasa J, Carbo M, Nadal-Gratacos N, Puigseslloses P, Espinosa-Velasco M Front Psychiatry. 2022; 13:990405.

PMID: 36262632 PMC: 9574023. DOI: 10.3389/fpsyt.2022.990405.


Synthetic cannabinoids use in a sample of opioid-use disorder patients.

Alias-Ferri M, Pellegrini M, Marchei E, Pacifici R, Rotolo M, Pichini S Front Psychiatry. 2022; 13:956120.

PMID: 35990071 PMC: 9381952. DOI: 10.3389/fpsyt.2022.956120.

References
1.
Aratani Y . Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018; 640:47-52. DOI: 10.1016/j.abb.2018.01.004. View

2.
Tournebize J, Gibaja V, Kahn J . Acute effects of synthetic cannabinoids: Update 2015. Subst Abus. 2016; 38(3):344-366. DOI: 10.1080/08897077.2016.1219438. View

3.
Scudamore O, Ciossek T . Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo. J Neuropathol Exp Neurol. 2018; 77(6):443-453. DOI: 10.1093/jnen/nly024. View

4.
Cardona-Benavides I, de Ramon C, Gutierrez N . Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications. Cells. 2021; 10(2). PMC: 7914805. DOI: 10.3390/cells10020336. View

5.
Simpson E, Brown H . Understanding osteosarcomas. JAAPA. 2018; 31(8):15-19. DOI: 10.1097/01.JAA.0000541477.24116.8d. View